Finished
Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy
NCT01544790 · UMC Utrecht · Updated 26 March 2020
- What is being tested
- Esophagectomy
- For
- Esophageal Carcinoma; Esophageal Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years to 75 years. About 112 people. The full rules are on the registry page.
- Where
- Netherlands
- When
- Starts or started April 2012, ends Aug 2016. Registered 6 March 2012.
- Results
- None posted yet.
In the researchers' words
This is the first randomized controlled trial designed to compare robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with open transthoracic esophagectomy as surgical treatment for resectable esophageal cancer. If our hypothesis is proved correct, robot-assisted minimally invasive thoraco-laparoscopic esophagectomy will result in a lower percentage of postoperative complications, lower blood loss, shorter hospital stay, but with at least similar oncologic outcomes and better postoperative quality of life compared with the open transthoracic esophagectomy (current standard).
Sites
- UMC UtrechtUtrecht, Netherlands